Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
1 other identifier
interventional
290
1 country
17
Brief Summary
A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started May 2001
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2001
CompletedFirst Submitted
Initial submission to the registry
October 26, 2001
CompletedFirst Posted
Study publicly available on registry
October 29, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2003
CompletedMay 30, 2011
May 1, 2011
1.8 years
October 26, 2001
May 27, 2011
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Allerganlead
Study Sites (17)
Eyecare of La Jolla
La Jolla, California, 92037, United States
UCLA
Los Angeles, California, 90095, United States
Opticare
Waterbury, Connecticut, 06708, United States
Brandon Eye Clinic
Tampa, Florida, 33629, United States
Emory University
Atlanta, Georgia, 30322, United States
UIC Eye Center
Chicago, Illinois, 60612, United States
Indiana University
Indianapolis, Indiana, 46202, United States
Hunkleler Eye Center
Overland Park, Kansas, 66211, United States
D'Ambrosio Eye Care
Leominster, Massachusetts, 01453, United States
Great Lakes Eye Institute
Saginaw, Michigan, 48604, United States
Cornea Consultants of Albany
Albany, New York, 12159, United States
Dr. Freedman's Office
Brooklyn, New York, 11201, United States
Dr. Wittpen's Office
Stony Brook, New York, 11790, United States
The Cole Eye Institute
Cleveland, Ohio, 44195, United States
Northwest Cornea
Portland, Oregon, 97223, United States
Corona Research
El Paso, Texas, 79903, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 26, 2001
First Posted
October 29, 2001
Study Start
May 1, 2001
Primary Completion
March 1, 2003
Study Completion
March 1, 2003
Last Updated
May 30, 2011
Record last verified: 2011-05